| 12/31/10 |
Lantheus Medical Imaging Commences Exchange Offer |
| 12/13/10 |
Lantheus Medical Imaging Announces FDA Accepts for Review DEFINITY®
Supplemental New Drug Application for Use in Stress Echocardiography |
| 12/06/10 |
Lantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99 |
| 10/14/10 |
Lantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada |
| 9/20/10 |
Lantheus Medical Imaging, Inc. to Present Clinical Data on Investigational Cardiac PET Imaging Agents at American Society of Nuclear Cardiology |
| 9/10/10 |
Lantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents |
| 7/15/10 |
Lantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India |
| 7/12/10 |
Lantheus Medical Imaging, Inc. Purchases Balance of Worldwide Rights for MRA Imaging Agent ABLAVAR® (Gadofosveset Trisodium) |
| 7/08/10 |
Lantheus Medical Imaging, Inc. Announces Agreement with MDS Nordion to Secure Additional Supply of Molybdenum-99 (Mo-99), a Key Medical Isotope |
| 6/14/10 |
Lantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY® at American Society of Echocardiography Annual Meeting |
| 6/09/10 |
Lantheus Medical Imaging, Inc. Presents Preliminary Data on Novel PET Myocardial Perfusion Imaging Agent Protocol at SNM Annual Meeting |
| 6/09/10 |
Lantheus Medical Imaging, Inc. Recognized as Top-Performing Supplier
by Premier Purchasing Partners, L.P. |
| 6/08/10 |
Lantheus Medical Imaging, Inc. Presents Phase 1 Data
Highlighting Safety, Dosimetry and Tolerability of Novel PET Heart Failure
Imaging Agent at SNM Annual Meeting |
| 6/07/10 |
Lantheus Medical Imaging, Inc. Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT at SNM Annual Meeting |
| 6/03/10 |
Lantheus Medical Imaging, Inc. to Present at Jefferies 2010 Global Life Sciences Conference |
| 6/03/10 |
Lantheus Medical Imaging, Inc. Announces Magnetic Resonance Angiography (MRA) Contract Award for ABLAVAR® With Amerinet, Inc. |
| 5/21/10 |
Lantheus Medical Imaging, Inc. Announces Increased Access to Medical Isotope Molybdenum-99 From Czech Nuclear Research Institute
|
| 5/19/10 |
Lantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting |
| 4/22/10 |
Lantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs |
| 3/16/10 |
Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158),
a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session |
| 03/09/10 |
Lantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and
Heart Failure Imaging Agents at the American College of Cardiology 59th Annual
Scientific Session in Atlanta |
| 02/17/10 |
Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing |
| 01/20/10 |
Lantheus Medical Imaging, Inc. Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent |
